| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,077 | 0,096 | 02.03. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Observe Medical ASA: Second half and full year interim report | 2 | Oslo Børs | ||
| 11.02. | OBSERVE MEDICAL ASA: Observe Medical are pleased to announce our entry into the Indian market - with its more than 1,4 billion inhabitants this represents a strategic move aligned with global healthcare growth trends | 2 | Cision News | ||
| 07.01. | Observe Medical ASA: Financial calendar | - | Oslo Børs | ||
| 19.12.25 | Observe Medical ASA - Received Innovation Norway Loan Commitment of NOK 15 million | 2 | Cision News | ||
| 12.12.25 | OBSERVE MEDICAL ASA: Observe Medical is expanding the portfolio within the Urological drainage segment and continued market penetration | 1 | Cision News | ||
| OBSERVE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 22.10.25 | Observe Medical ASA: Mandatory notification of trade by primary insider | 1 | Cision News | ||
| 22.10.25 | Observe Medical ASA: Mandatory notification of trade by close associates to primary insider | 2 | Cision News | ||
| 16.10.25 | Observe Medical ASA: Registration of new share capital | 1 | Oslo Børs | ||
| 14.10.25 | Observe Medical ASA: Mandatory notification of trade by close associates to primary insider | 2 | Cision News | ||
| 13.10.25 | Observe Medical ASA: Disclosure of major shareholdings following completion of the Private Placement and Subsequent Offering | 2 | Cision News | ||
| 13.10.25 | Observe Medical ASA: Final result of the subsequent offering and allocation of offer shares | 1 | Oslo Børs | ||
| 10.10.25 | OBSERVE MEDICAL ASA: Preliminary results of the subsequent offering | 1 | Cision News | ||
| 10.10.25 | Observe Medical ASA: Extraordinary general meeting held on 10 October 2025 | 1 | Oslo Børs | ||
| 10.10.25 | OBSERVE MEDICAL ASA: Last day of the subscription period in the subsequent offering | 2 | Oslo Børs | ||
| 07.10.25 | Observe Medical ASA: Observe Medical - Company presentation with trading update | - | Oslo Børs | ||
| 06.10.25 | Observe Medical ASA: Mandatory notification of trade by primary insider | 1 | Cision News | ||
| 25.09.25 | OBSERVE MEDICAL ASA: Observe Medical with progress in Italy: Major tender win, exclusive distribution agreement and significant order | 2 | Cision News | ||
| 25.09.25 | OBSERVE MEDICAL ASA: Approval and publication of prospectus, listing of the private placement shares and launch of subsequent offering | 1 | Oslo Børs | ||
| 24.09.25 | OBSERVE MEDICAL ASA: Resolution to increase the share capital in connection with subsequent offering | 2 | Cision News | ||
| 19.09.25 | Observe Medical ASA: Invitation to presentation with trading update 7 October, 2025 | 1 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,370 | -1,83 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 50,78 | -0,24 % | Aktien Frankfurt Ausblick: Dax-Stabilisierung über 25.000 Punkten erwartet | FRANKFURT (dpa-AFX) - Nach einem schwachen Wochenauftakt für den Dax können die Anleger am Dienstag auf eine Stabilisierung hoffen. Eine Stunde vor Handelsbeginn signalisierte der X-Dax als außerbörslicher... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,840 | +0,99 % | Einführung des neuen Dialysegeräts bremst Fresenius Medical Care in 2026 | BAD HOMBURG (dpa-AFX) - Nach einem Gewinnsprung 2025 dürfte sich die Dynamik beim Dialyseanbieter Fresenius Medical Care (FMC) Medicaldeutlich verlangsamen. Konzernchefin Helen Giza schließt für das... ► Artikel lesen | |
| GENEDX | 74,20 | -6,98 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| PROGYNY | 17,600 | 0,00 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen | ||
| PROCEPT BIOROBOTICS | 25,920 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,570 | +0,46 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,800 | -4,87 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| GERRESHEIMER | 16,120 | -4,90 % | ANALYSE-FLASH: UBS senkt Gerresheimer auf 'Sell' - Ziel mehr als halbiert | ZÜRICH (dpa-AFX) - Die Schweizer Großbank UBS hat das Kursziel für Gerresheimer von 29,00 auf 12,90 Euro eingestampft und die Aktien von "Neutral" auf "Sell" abgestuft. Olivier Calvet analysierte am... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,640 | +2,19 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 24,050 | +4,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,110 | -2,01 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,020 | +1,22 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,430 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |